Anecdotal reports suggest drugs like Ozempic may curb not just appetite but also impulsive or addictive behaviour, hinting at ...

The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

JACKSON, WY / ACCESS Newswire / April 1, 2025 / Labor Smart, Inc. (OTC PINK:LTNC), through its newest subsidiary Elevate ...

GLP-1 users are upping their purchases of frozen fruits (44%) and vegetables (40%) while reducing impulse purchases and ...

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching emerging channels and artificial ...

The prevalence of U.S. adults without diabetes who filled a GLP-1 receptor agonist prescription rose from 0.1% in 2018 to 0.4 ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

The Vitamin Shoppe ‘s Whole Health Rx is expanding its support for GLP-1 users.